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ABSTRACT
An 84-year-old woman was hospitalized due to consciousness disorder as hyperammonemia.  She 
had no etiology of liver disease.  Twelve months before the current admission, she had been diag-
nosed with dementia based on her low level of daily perception and physical activity.  Abdominal 
computed tomography revealed a large portosystemic shunt between the medial branch of the portal 
vein and middle hepatic vein.  After the improvement of her consciousness disturbance by medical 
treatment, percutaneous shunt embolization was electively performed.  The patient showed a re-
markable clinical improvement.  Consciousness disturbance caused by hyper-ammonemia might be 
underlying in dementia patients.  Increase of hepatopetal portal blood flow might have contributed to 
the improvement of her consciousness disturbance.  Embolization of the portosystemic shunt might 
be more effective for patients without liver disease as in the present case.
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Portosystemic shunts primarily occur in cases of 
portal hypertension with liver disease and subse-
quently can lead to portosystemic encephalopathy 
(PSE), a reversible brain dysfunction.  Although 
PSE has been reported to develop rarely in patients 
with portosystemic shunts without liver disease, 
these patients have often been diagnosed as having 
dementia or other psychiatric diseases2).  We de-
scribe a case of PSE without liver cirrhosis which 
was diagnosed as dementia and showed a remark-
able clinical improvement after shunt obliteration.
CASE REPORT
Case:
The patient was 84 years old woman.  She had 
no etiology of liver disease.  She was often referred 
to as dull.  Twelve months before the current ad-
mission, she was diagnosed as having dementia 
based on her Mini-Mental State Examination 
(MMSE) score 22.  Her family found her after los-
ing consciousness in their home and she was 
rushed to our hospital while unconscious.  Then, 
her degree of awakening was 10 (eye opening 3, 
verbal response 3, motor response 4) on the 
Glasgow Coma Scale (GCS) and biochemical exam-
ination indicated hyperammonemia.  We diagnosed 
unconsciousness caused by hyperammonemia and 
instilled a branched-chain amino acid preparation. 
After that, she recovered consciousness.  Abdomi-
nal computed tomography (CT) revealed a large 
portosystemic shunt between the medial branch of 
the portal vein and middle hepatic vein (Fig. 1).
Physical findings:
Height 148.5 cm, Weight 55.5 kg, GCS-10, flap-
ping tremor positive, anemia and jaundice not 
seen in palpebral conjunctiva or bulbar conjuncti-
va, flat and soft abdomen, back pain negative, liver 
and spleen not palpated, leg edema negative.
Blood and urine examinations at the hospital-
ization are shown in Table.
Increase of serum ammonia, blood sugar, blood 
urea nitrogen, and serum creatinine were noted. 
Although the levels of serum albumin and platelets 
were decreased, there were no markers of underly-
ing liver disease.
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Table 1. Blood examination at the hospitalization
CBC AST 13 IU/ liter Virus Markers
WBC 15800 /μl ALT 17 IU/ liter HBs antigen 0.00 IU/ml
RBC 4.28 × 106 /μl LDH 219 IU/ liter HCV antibody 0.1 C.O.I
MCV 89.7 fl ALP 282 IU/ liter Autoimmunity Markers
MCH 31.3 pg γ-GTP 25 IU/ liter ANA < ×40 times
MCHC 34.9 % Na 147 mEq/ liter AMA2 7.0 U/ml
Hb 13.4 g/dl K 4.7 mEq/ liter Tumor marker
Ht 38.4 % Cl 114 mEq/ liter AFP 8.5 ng/ml
Plt 14.5 × 103 /μl TP 7.1 g/dl DCP 17 mAU/ml
Alb 3.5 g/dl
BUN 59.1 mg/dl
Blood coagulation test Cr 0.99 mg/dl
PT 77.1 % CRP 2.26 mg/dl
PTT 28.4 S TC 198 mg/dl
APTT 28.4 S TG 115 mg/dl
fib 260 mg/dl FBS 231 mg/dl
HbA1c 6.4 %
Blood Chemistry NH3 243 μg/ml
T-Bil 1.1 mg/dl CPK 702 U/ liter
D-Bil 0.3 mg/dl AMY 28 U/ liter
AFP, a-fetoprotein; DCP, des-γ-carboxy prothrombin; Alb, albumin; ALP, alkaline phosphatase; 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatinine;  
CRP, c-reactive protein; FBS, fasting blood sugar level; Hb, hemoglobin; 
LDH, lactate dehydrogenase; Plt, platelets; PT, prothrombin time; RBC, red blood cells; 
T-Bil, total bilirubin; D-Bil, direct bilirubin;TC, total cholesterol; WBC, white blood cells;  
ANA, Anti-nuclear antibody;AMA2, anti-mitochondrial M2 antibody.
Fig. 1. Portal phase of enhanced CTs before and after embolization
(A) Pre-embolization.
  There was a large shunt (arrowheads) between two medial branches of the portal vein (large 
and small black arrows) and middle hepatic vein (large white arrows).
(B) Four months after embolization.
  The portosystemic shunt was completely embolized. Arrows show coils at the medial branches 
and the shunt.
B. Post Embolization (4 months)
A. Pre Embolization
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was directly measured as 9 mmHg.  Sandwich em-
bolization technique was used for obliteration of 
the large portosystemic shunt.  First, for stopping 
outflow from the shunt, an Amplatzer vascular 
plug II of 20 mm diameter was deployed at the 
middle hepatic vein through a right jugular vein 
approach.  Secondly, for stopping the inflow into 
the shunt, nine detachable microcoils and two 
pushable microcoils from 7 mm to 14 mm diameter 
were placed at the medial branches of portal vein 
through a transhepatic direct approach of a right 
portal branch.  Shunt obliteration was completely 
achieved without complications (Fig. 2).
CLINICAL COURSE
After admission to our hospital, her consciousness 
became clear.  The diagnosis of PSE was confirmed 
by elevated serum ammonia levels of 243 μg/dl (nor-
mal, < 66) and a portosystemic shunt between the 
medial branch of portal vein and middle hepatic vein 
on abdominal enhanced CT.  We considered that a 
portosystemic shunt might influence her competency 
for affiliation because she had no etiology of liver dis-
ease.  We electively performed shunt obliteration.
The shunt embolization procedure was as fol-
lows.  Before embolization, portal blood pressure 
Fig. 3. Clinical course
Although the level of consciousness was improved with intravenous BCAA, intra-colonic lactulose, 
and antibiotics after the first admission, the low competency for affiliation and hyperammonemia 
remained. However, after shunt obliteration, the hyperammonemia disappeared, and both the score 
of Mini-Mental State Examination (MMSE) and the stage of PSE were dramatically improved. BTR 









































Fig. 2. Portographies before and after embolization
(A) Early and (B) delayed phase of pre-embolizations. 
  There was an aneurysmal change of shunt (arrowheads) between the dilated medial branches of 
portal vein (black arrow) and middle hepatic vein (white arrow).
(B) After embolization.
 The portosystemic shunt was completely obliterated.
(B) (C)(A)
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plaints due to portal hypertension were registered. 
Furthermore, BTR (branched chain amino acids / 
tyrosine molar ratio) and serum albumin were 
raised.  We presume it reflects an increase of the 
portal flow volume into the liver parenchyma.
CONCLUSION
In a case of unstable dementia accompanied by 
symptoms similar to PSE, the possibility of a por-
tosystemic shunt and hyperammonemia should be 
considered in spite of the presence or absence of 
underlying liver disease.
The embolization of a portosystemic shunt 
might be more effective, especially for patients 
without liver disease.
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Figure 3 shows the clinical course.  After obliter-
ation of the shunt, the hyperammonemia disap-
peared.  Both the MMSE score and PSE stage were 
dramatically improved.  Six months after shunt 
obliteration, (Cancel: there was no recurrence of 
portosystemic shunt nor appearance of ectopic 
shunt) the patient is living a completely indepen-
dent life.
DISCUSSION
The present case of PSE occurred in a patient 
without liver disease, who had been continuously 
treated for dementia.  Other cases complicated by 
both PSE and dementia have been reported, as in 
our case1,5).  However, it is difficult to diagnose 
their pathophysiology correctly, because they show 
poor findings of chronic liver disease and tend to 
focus on dementia or some kind of psychiatric dis-
ease.  Watanabe et al7) reported characteristics 
suspiciously like those of PSE in patients without 
liver disease, as below: (a) High serum ammonia 
levels with no or slightly abnormal liver function. 
(b) The repeated development of psychiatric-like 
symptoms.  (c) Abnormally large vessels connected 
with portal flow detected on enhanced abdominal 
CT.  In the present case, we found all of these 
characteristics and they provided useful clues for 
the diagnosis.  The apparent reasons for late diag-
nosis were that the patient had no history of liver 
disease, serum ammonia was not routinely mea-
sured, and PSE was not suspected.
It is reported that the etiology of PSE without 
liver cirrhosis includes congenital abnormalities in 
the intrahepatic vascular system, degeneration of 
hepatic parenchyma and anastomosing vascular-
ization after abdominal surgery, liver biopsy or 
trauma2).  In the present case, the patient received 
abdominal surgery for colon cancer 13 years ago, 
and showed abnormally large vessels connected by 
the intrahepatic portal vein.  When we consider 
this, the etiology of the present case might be re-
lated to congenital abnormalities in the intrahe-
patic vascular system.  If so, we should consider 
why PSE never occurred before this episode.  Am-
monia is mainly metabolized in the urea cycle in 
the liver.  In addition to the liver, for the ammonia 
flux, skeletal myocytes provide ammonia metabo-
lism by incorporating ammonia into glutamine via 
glutamine synthetase3).  The reason for hyperam-
monemia in this case might be the decrease of 
skeletal myocytes due to aging or lower activity in 
daily life.
The utility of a intrahepatic portosystemic shunt 
for embolization has been reported4,6,8).  Six months 
after embolization, significant improvement was 
observed in the patient’s clinical status, and no 
signs of recurrent hepatic encephalopathy or com-
